Samir Panjwani joins Trailblazers to speak about a new era of CDMO sourcing, and shares examples of the data he discovers and shares in his CDMO Signal that go far beyond capabilities and capacity.

Jerry Jiang, Vice President of Global Sales at CellBri, joins the Trailblazers to discuss how automation can help make cell therapies less expensive and more accessible. He shares how CellBri is working to automate cell therapy processing, how its global footprint...

Joe Renny, Head of Corporate Development at CatSci, returns to Trailblazers to explore whether a new Cold War is emerging around pharmaceutical innovation. He and Perry Rearick discuss China’s growing role in drug discovery, the push for scientific and supply chain...

Bob File joins the Trailblazers to discuss technology, digital transformation & AI, and how life sciences and clinical trials are being impacted. He reminds us that human beings in the loop are the most important feature of AI. Bob is also a former Major League...

New cell and gene therapy clinical breakthroughs & manufacturing innovations are emerging quickly in a field characterized by scientific acceleration. It is awfully difficult for CDMOs to effectively communicate their capabilities, let alone establish a new brand in...